InMode (INMD) Total Current Liabilities (2018 - 2026)
InMode (INMD) posted quarterly Total Current Liabilities of $77.4 million for Q1 2026, up 6.46% year-on-year from $72.7 million in Q1 2025, and up 9.34% on a QoQ basis from $70.7 million in Q4 2025.
InMode (INMD) Total Current Liabilities (2018 - 2026) Analysis & Trends
InMode (INMD) has reported Total Current Liabilities for 9 consecutive years, with $77.4 million the latest figure, recorded in Q1 2026.
- Quarterly Total Current Liabilities rose 6.46% year-over-year to $77.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $77.4 million (up 6.46% YoY) and the FY2025 annual result came in at $70.7 million, up 1.28% from the prior year.
- Total Current Liabilities grew to $77.4 million in Q1 2026 per INMD's latest filing, from $70.7 million in the prior quarter.
- Over the last five years, Total Current Liabilities for INMD reached as high as $97.7 million in Q2 2024 and fell as low as $49.8 million in Q1 2022.
- A 5-year average of $68.1 million and a median of $66.5 million in 2025 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2024 — Total Current Liabilities soared 60.85% — and 2025, when it slumped 31.89%.
- Year by year, Total Current Liabilities stood at $82.0 million in 2022, then fell by 21.8% to $64.1 million in 2023, then grew by 8.91% to $69.9 million in 2024, then climbed by 1.28% to $70.7 million in 2025, then advanced by 9.34% to $77.4 million in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $77.4 million, $70.7 million, and $68.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.22 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.70 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.60 Bn |
| 10 | InMode | 956,721.10 | -479.17 Mn | 61.55 Mn | 77.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 77.35 Mn |
| Dec 31, 2025 | 70.74 Mn |
| Sep 30, 2025 | 68.33 Mn |
| Jun 30, 2025 | 66.53 Mn |
| Mar 31, 2025 | 72.66 Mn |
| Dec 31, 2024 | 69.85 Mn |
| Sep 30, 2024 | 75.70 Mn |
| Jun 30, 2024 | 97.69 Mn |
| Mar 31, 2024 | 65.00 Mn |
| Dec 31, 2023 | 64.14 Mn |
| Sep 30, 2023 | 62.19 Mn |
| Jun 30, 2023 | 60.73 Mn |
| Mar 31, 2023 | 59.67 Mn |
| Dec 31, 2022 | 82.02 Mn |
| Sep 30, 2022 | 57.93 Mn |
| Jun 30, 2022 | 57.99 Mn |
| Mar 31, 2022 | 49.82 Mn |
| Dec 31, 2021 | 51.85 Mn |
| Sep 30, 2021 | 53.87 Mn |
| Jun 30, 2021 | 42.17 Mn |